GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Movano Inc (NAS:MOVE) » Definitions » ROCE %

Movano (Movano) ROCE % : -561.55% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Movano ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Movano's annualized ROCE % for the quarter that ended in Dec. 2023 was -561.55%.


Movano ROCE % Historical Data

The historical data trend for Movano's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Movano ROCE % Chart

Movano Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial -238.96 -241.70 -107.21 -147.47 -503.78

Movano Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -274.80 -292.82 -241.76 -401.73 -561.55

Movano ROCE % Calculation

Movano's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-29.69/( ( (13.243 - 4.978) + (9.421 - 5.899) )/ 2 )
=-29.69/( (8.265+3.522)/ 2 )
=-29.69/5.8935
=-503.78 %

Movano's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=-24.096/( ( (10.593 - 5.533) + (9.421 - 5.899) )/ 2 )
=-24.096/( ( 5.06 + 3.522 )/ 2 )
=-24.096/4.291
=-561.55 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Movano  (NAS:MOVE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Movano ROCE % Related Terms

Thank you for viewing the detailed overview of Movano's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Movano (Movano) Business Description

Traded in Other Exchanges
N/A
Address
6800 Koll Center Parkway, Pleasanton, CA, USA, 94566
Movano Inc is a health-focused technology company developing simple, smart, and personalized devices designed to help individuals on their health journey maintain good health today and prevent and manage chronic diseases in the future. It is developing a proprietary platform that uses Radio Frequency (RF) technology. It enables the creation of low-cost and scalable sensors that fit into wearable and other small form factors.
Executives
Jeremy Cogan officer: CFO 6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Michael Aaron Leabman director, officer: CEO and President 207 VERITAS CT, SAN RAMON CA 94582
Emily Fairbairn director 10 ORINDA VIEW ROAD, ORINDA CA 94563
John Mastrototaro director 6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Brian Cullinan officer: CFO 6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Nan Kirsten Forte director 111 EIGHTH AVENUE, NEW YORK NY 10011
Ruben Caballero director C/O RESONANT INC. 10900 STONELAKE BLVD., SUITE 100, OFFICE 02-130, AUSTIN TX 78759
Dvine Irrevocable Trust 10 percent owner 6200 STONERIDGE MALL RD., SUITE 300, PLEASANTON CA 94588
Gregory S Tamkin 10 percent owner 303 RAY STREET, PLEASANTON CA 94566
Dorsey & Whitney Trust Co Llc 10 percent owner 401 EAST EIGHTH STREET, SUITE 319, SIOUX FALLS SD 57103
William Tai-wei Ho 10 percent owner C/O IN8BIO, INC., 79 MADISON AVENUE, NEW YORK NY 10016